Skip Nav Destination
Issues
15 January 2011
-
Cover Image
Cover Image
Immunofluorescence analysis demonstrating the cytoplasmic localization of galectin-3 in CD18/HPAF pancreatic cancer cells transfected with scramble control vector. The cells were grown at low density on sterile cover slips for 20 hours. After washing with 0.1 M HEPES-containing Hanks buffer, the cells were fixed in ice-cold methanol at −20°C for 2 minutes. After nonspecific blocking with 10% goat serum, cells were incubated with antigalectin-3 antibody in PBS for 90 minutes at room temperature. Cells were washed 3 to 4 times with PBS containing 0.05% Tween-20 (PBS-T) and then incubated with FITC-conjugated anti-rat secondary antibodies for 60 minutes. The cells were counterstained with propidium iodide. Finally, slides were washed, mounted, and observed under a ZEISS confocal laser-scanning microscope. Photographs were digitally captured by using 510-software. For further details, please see Senapati and coworkers on page 267 in this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
Molecular Pathways
Review
Decreasing the Adverse Effects of Cancer Therapy: National Cancer Institute Guidance for the Clinical Development of Radiation Injury Mitigators
Benjamin Movsas; Bhadrasain Vikram; Martin Hauer-Jensen; John E. Moulder; Ethan Basch; Stephen L. Brown; Lisa A. Kachnic; Adam P. Dicker; C. Norman Coleman; Paul Okunieff
Human Cancer Biology
Extent and Patterns of MGMT Promoter Methylation in Glioblastoma- and Respective Glioblastoma-Derived Spheres
Davide Sciuscio; Annie-Claire Diserens; Kristof van Dommelen; Danielle Martinet; Greg Jones; Robert-Charles Janzer; Claudio Pollo; Marie-France Hamou; Bernd Kaina; Roger Stupp; Marc Levivier; Monika E. Hegi
Cancer Therapy: Preclinical
Modulating Endogenous NQO1 Levels Identifies Key Regulatory Mechanisms of Action of β-Lapachone for Pancreatic Cancer Therapy
Long Shan Li; Erik A. Bey; Ying Dong; Jieru Meng; Biswanath Patra; Jingsheng Yan; Xian-Jin Xie; Rolf A. Brekken; Carlton C. Barnett; William G. Bornmann; Jinming Gao; David A. Boothman
Imaging, Diagnosis, Prognosis
β-Catenin Activation Is Associated with Specific Clinical and Pathologic Characteristics and a Poor Outcome in Adrenocortical Carcinoma
Sébastien Gaujoux; Sophie Grabar; Martin Fassnacht; Bruno Ragazzon; Pierre Launay; Rossella Libé; Ilham Chokri; Anne Audebourg; Benedict Royer; Silviu Sbiera; Marie-Cécile Vacher-Lavenu; Bertrand Dousset; Xavier Bertagna; Bruno Allolio; Jérôme Bertherat; Frédérique Tissier
Cancer Therapy: Clinical
Primary CNS Lymphoma in Children and Adolescents: A Descriptive Analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG)
Oussama Abla; Sheila Weitzman; Jean-Yves Blay; Brian Patrick O'Neill; Lauren E. Abrey; Edward Neuwelt; Nancy D. Doolittle; Joachim Baehring; Kamnesh Pradhan; S. Eric Martin; Michael Guerrera; Shafqat Shah; Hervé Ghesquieres; Michael Silver; Rebecca A. Betensky; Tracy Batchelor
Phase I and Pharmacokinetic Study of CT-322 (BMS-844203), a Targeted Adnectin Inhibitor of VEGFR-2 Based on a Domain of Human Fibronectin
Anthony W. Tolcher; Christopher J. Sweeney; Kyri Papadopoulos; Amita Patnaik; Elena G. Chiorean; Alain C. Mita; Kamalesh Sankhala; Eric Furfine; Jochem Gokemeijer; Lisa Iacono; Cheryl Eaton; Bruce A. Silver; Monica Mita
Predictive Biomarkers and Personalized Medicine
Impact of Exploratory Biomarkers on the Treatment Effect of Bevacizumab in Metastatic Breast Cancer
Adrian M. Jubb; Kathy D. Miller; Hope S. Rugo; Adrian L. Harris; Dafeng Chen; James D. Reimann; Melody A. Cobleigh; Maike Schmidt; Virginia K. Langmuir; Kenneth J. Hillan; Daniel S. Chen; Hartmut Koeppen
Advertisement